PROVECTUS BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,071 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 26-50 of 51 matching filings.

Per page
25
Current page
2
10-Q File 001-36457

10-Q filing

Filing date
09 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
10-Q File 001-36457

10-Q filing

Filing date
08 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
10-Q File 001-36457

10-Q filing

Filing date
09 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
10-Q/A File 000-09410

10-Q/A filing

Filing date
25 Jul 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-09410

10-Q filing

Filing date
10 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-09410

PVCT 10-Q 09-30-10

Filing date
15 Nov 2010
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-09410

PVCT 10-Q 06-30-10

Filing date
13 Aug 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .